HLA-DR expression is a significant prognostic factor in laryngeal cancer. A morphometric study

APMIS

Volumn 107, Issue 4, 1999, Pages 383-388

  Sikorska, Beata ^a   Danilewicz, Marian ^b   Wagrowska Danilewicz, Malgorzata ^b  

^a UNIVERSITY OF LODZ   (Poland)

^b NONE

Author keywords

HLA DR; Laryngeal cancer; Prognosis

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CANCER SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCHEMISTRY; LARYNX CANCER; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL TIME;

EID: 0032894149     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01569.x     Document Type: Article

References (35)

1. 1. Accola, R. S., Scupoli, M. T. & Cambiaggi, C.: Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression. Int. J. Cancer Suppl. 6: 20-25, 1991.
2. 2. Bigotti, G., Coli, A. & Castagnola, D.: Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade. Prostate 19: 73-83, 1991.
3. 3. Blumenfeld, W., Ye, J.-Q., Dahiya, R. & Griffiss, J. M.: HLA expression by benign and malignant prostatic epithelium: augmentation by interferon-gamma. J. Urol. 150: 1289-1292, 1993.
4. 4. Cabrera, T., Ruiz-Cabello, F. & Garrido, F.: Biological implications of HLA-DR expression in tumours. Scand. J. Immunol. 41: 398-406, 1995.
5. 5. Esteban, F., Ruiz-Cabello, F. & Conches, A.: HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx. Clin. Exp. Metast. 8: 319-328, 1990.
6. 6. Ferlito, A., Harrison, D., Bailey, B., & DeSanto, L.: Are clinical classifications for laryngeal cancer satisfactory? Ann. Otol. Rhinol. Laryngol. 104: 741-747, 1995.
7. 7. Helweg-Larsen, K., Graem, N., Meistrup-Larsen, K. & Meistrup-Larsen, U.: Clinical relevance of histological grading of cancer of the larynx. Acta path. microbiol. scand. Sect. A 86: 499-504, 1978.
8. 8. Hilders, C., Houbiers, J. G. A. & Krul, J. T.: The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma. Am. J. Clin. Pathol. 101: 5-12, 1994.
9. 9. Horiuchi, K. & Mishima, K.: Prognostic factors for well-differentiated squamous cell carcinoma in the oral cavity with emphasis on immunohistochemical evaluation. J. Surg. Oncol. 53: 92-96, 1993.
10. 10. Houck, J., Sexton, M. & Zajdel, G.: HLA class I and class II antigen expression on squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg. 116: 1181 1185, 1990.
11. 11. Inoue, K., Furihata, M., Ohtsuki, Y. & Fujita, Y.: Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch. A 422: 351-355, 1993.
12. 12. Ioachim-Velogianni, E., Stavropoulos, N., Kitsiou, E., Stefanaki, S. & Agnatis, N.: HLA-DR antigen expression and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections. J. Pathol. 174: 183-189, 1994.
13. 13. Jakobsson, P., Eneroth, C.-M., Killander, D., Moberger, G. & Martensson, B.: Histologic classification and grading of malignancy in carcinoma of the larynx. Acta Radiol. Ther. Phys. Biol. 12: 1-8, 1973.
14. 14. Kleinsasser, O.: Revision of classification of laryngeal cancer, is it long overdue? J. Laryngol. Otol. 106: 197-204, 1992.
15. 15. Kressenstein, S., Falk, C., Reinhardt, C., Maget, B. & Schendel, D.: Influence of IFN-γ on human renal cell carcinomas and their altered recognition by tumor-infiltrating lymphocytes and lymphokine-activated killer cells. Immunobiology 191: 214, 1994.
16. 16. Lund, C., Sogaard, H., Elbrond, O., Hjelm-Hansen, M. & Andersen, A.: Histological grading of epidermoid carcinomas in the head and neck. Dan. Med. Bull. 24: 162-166, 1977.
17. 17. Manni, J., Terhaard, C., de Boer, M., Croll, G., Higers, F., Annyas, A., van der Meji, A. & Hordijk, G.: Prognostic factors for survival in patients with T3 laryngeal carcinoma. Am. J. Surg. 164: 682-687, 1992.
18. 18. Matijssen, V., De Mulder, P., Schalkwijk, L., Manni, J., Van't Hof-Grootenboer, B. & Ruiter, D.: HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sites. Int. J. Cancer Suppl. 6: 95-100, 1991.
19. 19. Matsuhita, K., Takenouchi, T., Kobayashi, S., Hayashi, H., Okuyama, K., Ochiai, T., Mikata, A. & Isono, K.: HLA-DR antigen expression on colorectal carcinomas: influence of expression by IFN-γ in situ and its association with tumour progression. Br. J. Cancer 73: 644-648, 1996.
20. 20. Norheim-Andersen, S. & Rognum, T. O.: Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br. J. Cancer 68: 80-85, 1993.
21. 21. Ostrand-Rosenberg, S., Roby, C., Clements, V. & Cole, G.: Tumor-specific immunity can be enhanced by transfection of tumor cells with syngeneic MHC-class-II genes or allogeneic MHC-class-I genes. Int. J. Cancer Suppl. 6: 61-68, 1991.
22. 22. Pradier, R. & Gonzalez, A.: Prognostic factors in laryngeal carcinoma. Experience in 296 male patients. Cancer 71; 2472-2476, 1993.
23. 23. Rammensee, H.-G.: Antigen presentation - recent developments. Int. Arch. Allergy Immunol. 110: 299-307, 1996.
24. 24. Resta, L., Assenato, G., Fiorella, R., Russo, S., Colucci, G. & DiNicola, V.: Multivariate analysis of metastasis risk in laryngeal carcinoma. I. Tumor factors. Boll. Soc. Ital. Biol. Sper. 67: 191-198, 1991.
25. 25. Rinaldo, C. R. Jr.: Modulation of major histocompatibility complex antigen expression by viral infection. Am. J. Pathol. 144: 637-650, 1994.
26. 26. Ruiter, D. J., Brocker, E. B. & Ferrone, S.: Expression and susceptibility to modulation by interferons of HLA class I and II antigens on melanoma cells. Immunohistochemical analysis and clinical relevance. J. Immunogenet. 13: 229-234, 1986.
27. 27. Sadanaga, N. & Kuwano, H.: Local immune response to tumour invasion in esophageal squamous cell carcinoma. Cancer 74: 586-591, 1994.
28. 28. Silvestri, F. & Bussani, R.: Supraglottic versus glottic laryngeal cancel: epidemiological and pathological aspects. ORL J. Otorhinolaryngol. Relat. Spec. 54: 43-48. 1992.
29. 29. Stell, P. M.: Prognosis in laryngeal carcinoma: tumour factors. Clin. Otolaryngol. 15: 69-81, 1990.
30. 30. Stell, P. M.: Prognostic factors in laryngeal carcinoma. Clin. Otolaryngol. 13: 399-409, 1988.
31. 31. Tomita, Y., Matsumoto, Y,. Nishiyama, T. & Fujiwara, M.: Reduction of major histocompatibility complex class I antigens on invasive and high-grade transitional cell carcinoma. J. Pathol. 162: 157-164, 1990.
32. 32. Tomita, Y., Nishiyama, T., Fujiwara, M. & Sato, S.: Immunohistochemical detection of major histocompatibility complex antigens and quantitative analysis of tumour-infiltrating mononuclear cells in renal cell cancer. Br. J. Cancer 62: 354-359, 1990.
33. 33. Torii, A. & Harada, A.: Expression of HLA DR in intrahepatic cholangiocarcinoma. Cancer 70: 1057-1061, 1992.
34. 34. Weibel, E. R.: Stereological Methods. Vol. I. Practical methods for biological morphometry. Academic Press, London, New York, Toronto, San Francisco 1979.
35. 35. Zetterstrom, U., Wennerberg, J., Ewers, S., Willen, R. & Attewell, R.: Prognostic factors in head and neck cancer: histologic grading. DNA ploidy, and nodal status. Head Neck 13: 477-487, 1991.